Merck Life Science in India recently signed a Memorandum of Understanding (MoU) with GeNext Genomics Pvt Ltd, an emerging biotech company.

The MoU was signed between Aditya Sharma, Dr. Ashwin kashikar, Managing Director, Genext Genomics Pvt. Ltd; in the presence of Supriya Kashikar, Founder & CEO, GeNext Genomics Pvt Ltd and Ravi Kashikar, Chairman and Founder of Ankur Seeds.

This collaboration creates a unique competitive edge by combining local expertise with global biomanufacturing capabilities. By partnering with Merck for their world-class expertise in biomanufacturing, Genext Genomics can now offer comprehensive solutions that support the growth of India’s biotech ecosystem.